Activists demand compulsory licence for another life-saving cancer drug

Appellate board's order upholding Natco's CL for sorafenib tosylate may pave way for manufacture of generic version of other patented drugs

Indian company gets licence to manufacture and sell patented cancer drug

This is the first-ever compulsory licence given to a generic drug company